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Hyperpolarisation of weakly binding N-
heterocycles using signal amplification by
reversible exchange†
Peter J. Rayner, Joseph P. Gillions, Valentin D. Hannibal, Richard O. John
and Simon B. Duckett *
Signal Amplification by Reversible Exchange (SABRE) is a catalytic method for improving the detection of
molecules by magnetic resonance spectroscopy. It achieves this by simultaneously binding the target
substrate (sub) and para-hydrogen to a metal centre. To date, sterically large substrates are relatively
inaccessible to SABRE due to their weak binding leading to catalyst destabilisation. We overcome this
problem here through a simple co-ligand strategy that allows the hyperpolarisation of a range of weakly
binding and sterically encumbered N-heterocycles. The resulting 1H NMR signal size is increased by up
to 1400 times relative to their more usual Boltzmann controlled levels at 400 MHz. Hence, a significant
reduction in scan time is achieved. The SABRE catalyst in these systems takes the form
[IrX(H)2(NHC)(sulfoxide)(sub)] where X ¼ Cl, Br or I. These complexes are shown to undergo very rapid
ligand exchange and lower temperatures dramatically improve the efficiency of these SABRE catalysts.
Hyperpolarised magnetic resonance is receiving increasing
attention from both the analytical science and medical
communities due to its ability to create signals that are many
orders of magnitude higher than those normally detected under
Boltzmann control.1–6 The time and cost benets associated
with this improvement have propelled this area of research
forward over the past few decades. Two of the most prominent
techniques used to create hyperpolarisation are dissolution
Dynamic Nuclear Polarisation (d-DNP) and Para-Hydrogen
Induced Polarisation (PHIP),7,8 which derive their non-
Boltzmann spin energy level populations from interactions
with unpaired electrons and para-hydrogen (p-H2, the singlet
spin isomer of hydrogen), respectively. Both of these methods
have been reviewed in detail.3–5,9,10
Signal Amplication by Reversible Exchange (SABRE) is
a PHIP method that does not involve the chemical incorpora-
tion of p-H2 into the target substrate.
11,12 Instead, under SABRE,
spin order transfer proceeds catalytically through the temporary
formation of a scalar coupling network between p-H2 derived
hydride ligands and the substrate's nuclei whilst they are
located in a transient metal complex. The most common cata-
lysts are of the type [Ir(H)2(NHC)(sub)3]Cl (where NHC ¼ N-
heterocyclic carbene and sub ¼ the substrate of interest,
Fig. 1a),13,14 although other variants are known.15–17 For SABRE
to be accomplished, the target substrate must be able to
reversibly ligate to the metal centre and this limits the methods
applicability; although several routes to overcome this have
been reported.18–20 Recently, the use of bidentate ancillary
ligands such as NHC-phenolates16 and phosphine-oxazoles21
Fig. 1 Development of the SABRE method for hyperpolarisation of
a range of substrates.
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has been shown to expand the applicability of SABRE for
a variety of different ligands and solvents (Fig. 1b). For example,
use of the PHOX ligand (PHOX ¼ (2-diphenylphosphanyl)
phenyl-4,5-dihydrooxazole) gives 1H NMR signal gains of up to
132-fold for 2-picoline; a substrate previously shown to be
unpolarised under classic SABRE conditions.22
The use of co-ligands to stabilise the active SABRE catalyst
has proven successful for substrates that weakly associate to the
catalyst (Fig. 1c). Of particular note is the hyperpolarisation of
sodium [1,2]-13C2-pyruvate
23 and sodium 13C-acetate24 which
could be used as in vivometabolic probes. The importance of co-
ligands in breaking the chemical symmetry of the SABRE cata-
lyst is also well established and co-ligands such as acetonitrile,25
sulfoxides,23,26 1-methyl-1,2,3-triazole27 and substrate iso-
topologues28 have been employed.
We report here on the use of co-ligands to allow the NMR
hyperpolarisation of weakly binding N-heterocyclic derived
substrates with functionality in the ortho-position that have
proven to be routinely inaccessible to the SABRE technique
(Fig. 1d). 1H signal gains of up to 1442  84-fold were obtained
for some of these substituted pyridines at 9.4 T and the
expansion of this approach to 13C and 15N detection and other
N-heterocyclic motifs is also exemplied.
Results and discussion
Under standard SABRE conditions, ([IrCl(COD)(IMes)] (5 mM)
and substrate (20 mM) in either methanol-d4 or dichloro-
methane-d2 (0.6 mL)), we conrm
22 that no 1H based polar-
isation enhancements are observed aer polarisation transfer
at 70 G under 3 bar p-H2 for an array of 2-substituted pyridines
including 2-picoline and 2,5-lutidine. Additionally, there is no
evidence of any hydride containing complexes being formed
under these conditions when probed by either PHIP or low
temperature NMR experiments. Presumably, this is due to the
substrates weak ligation ability due to steric constraints around
the metal centre caused by the substituents that lie ortho to the
nitrogen binding site.
To overcome these limitations, we hypothesised that using
a weakly binding co-ligand could allow for the formation of
stable yet active SABRE catalysts. The key requirement for a co-
ligand being that it will bind to the metal centre with compa-
rable affinity to the target substrate, in order for the target
substrate itself not to be completely displaced. Previously,
sulfoxide co-ligands have fullled this role23,26,29 and, therefore,
a sample was prepared that contained [IrCl(COD)(IMes)] (5
mM), 2,5-lutidine (20 mM) and DMSO-d6 (30 mM) in methanol-
d4 and it was exposed to 3 bar H2 for 1 h at room temperature.
Aer this time, p-H2 (3 bar) was added and the sample was
shaken in a 70 G eld before being rapidly inserted into a 9.4 T
spectrometer for NMR analysis. Pleasingly, a 90  7-fold 1H
NMR signal enhancement was observed for the H6 resonance of
2,5-lutidine in the resulting spectrum when compared to the
corresponding control spectrum obtained under Boltzmann
conditions. The hydride region of this 1H NMR spectrum now
contained hydride resonances for multiple (>6, see ESI†) PHIP
enhanced dihydride complexes; each of which could be
responsible for the observed SABRE transfer.
When the same SABRE experiment was repeated using
dichloromethane-d2 as the solvent, the observed signal
enhancement for 2,5-lutidine signicantly improves. Now, a 215
 13-fold signal gain was quantied for the H6 resonance of 2,5-
lutidine. Additionally, just two hydride-containing complexes
are now present in solution (Fig. 2). The rst complex exhibits
hydride resonances at d 16.0 and 21.4 and is assigned to
[IrCl(H)2(IMes)(DMSO-d6)2] on the basis of comparison to
literature data.29 The second complex has hydride resonances at
d 23.0 and 23.5 and these are attributed to [IrCl(H)2(-
IMes)(DMSO-d6)(2,5-lutidine)]. In this species, the 2,5-lutidine
and chloride ligands lie cis to one another and trans to hydride.
These two complexes exist in a ca. 1 : 2 ratio respectively when
the initial ratio of DMSO to 2,5-lutidine is 3 : 2. Under PHIP
conditions, the enhanced hydride signals exhibit an intensity
ratio of 1 : 4 aer interrogation with a 45 pulse, thereby indi-
cating a rapid H2 exchange pathway via [IrCl(H)2(-
IMes)(DMSO)(2,5-lutidine)]. In this spectrum, a minor hydride-
containing complex also becomes visible with resonances at
d 13.57 and 17.96 which we attribute to the isomeric form of
[IrCl(H)2(IMes)(DMSO-d6)(2,5-lutidine)] where the DMSO-d6 lies
Fig. 2 SABRE hyperpolarisation of 2,5-lutidine via precursor [IrCl(-
COD)(IMes)] and the co-ligand DMSO-d6 in dichloromethane-d2
solution. (a) Schematic of formation of complexes [IrCl(H)2(-
IMes)(DMSO-d6)2] and [IrCl(H)2(IMes)(DMSO-d6)(2,5-lutidine)]. (b)
SABRE hyperpolarised 1H NMR spectrum of 2,5-lutidine after polar-
isation transfer at 70 G with 3 bar p-H2 and detection using a 90

flip
angle. (c) PHIP enhanced hydride region of the hyperpolarised 1HNMR
spectrum collected using a 45 flip angle.
Chem. Sci. © 2021 The Author(s). Published by the Royal Society of Chemistry













































































































in the equatorial plane and the 2,5-lutidine is trans to the NHC
ligand. Overall, rapid ligand exchange in this catalytic system is
supported by the fact that the free H2 peak is broadened (30 Hz
width at half height) and shied to 4.52 ppm which differs from
the usual 4.64 ppm value.
When the complex [IrCl(H)2(IMes)(DMSO-d6)2] is examined
in the absence of 2,5-lutidine, the free H2 peak appears at
4.62 ppmwith a half-width of 12 Hz which suggests a slower rate
of hydride/hydrogen exchange in this complex when isolated.
The rate of hydride ligand loss from [IrCl(H)2(IMes)(DMSO-
d6)(2,5-lutidine)] to form H2 was also quantied to be 8.78 
0.40 s1 at 273 K. The corresponding rate of 2,5-lutidine loss
was 9.64  0.21 s1 at 273 K. Ligand exchange at 298 K was too
rapid to be accurately determined using EXSY methods.
Density functional theory (DFT) conrms that [IrCl(H)2(-
IMes)(DMSO)(2,5-lutidine)] is the most energetically stable
complex in solution, whilst [IrCl(H)2(IMes)(DMSO)2] is pre-
dicted to be 12.2 kJ mol1 higher in energy. Other potential
complexes such as [Ir(H)2(IMes)(DMSO)2(2,5-lutidine)]Cl or the
classical SABRE complex [Ir(H)2(IMes)(2,5-lutidine)3]Cl are dis-
favoured with free energy values that are 71.4 and 74.7 kJ mol1
higher than [IrCl(H)2(IMes)(DMSO)(2,5-lutidine)] respectively
(see ESI†). Interestingly, we note that despite the fused bicyclic
nature of quinoline, DFT suggests that [IrCl(H)2(-
IMes)(DMSO)(quinoline)] is 9.0 kJ mol1 more stable than its
2,5-lutidine analogue; this ligand is hyperpolarised later in this
manuscript.
Role of sulfoxide co-ligand in active SABRE catalyst formation
The identity of the sulfoxide co-ligand proved to exhibit
a signicant impact on the level of the 2,5-lutidine NMR signal
gains and the appearance of the free H2 signal. It was found that
the use of methyl phenyl sulfoxide increased the 1HNMR signal
gain for the H6 2,5-lutidine position to 319 32 in an analogous
dichloromethane-d2 sample. Even higher signal enhancements
of 723  38-fold were achieved when diphenylsulfoxide (DPSO)
was the co-ligand. No evidence was observed for the formation
of the analogous bis-sulfoxide complex, [IrCl(H)2(-
IMes)(DPSO)2], was seen by either PHIP or low temperature
NMR measurements. [IrCl(H)2(IMes)(DPSO)(2,5-lutidine)],
which has hydride resonances at d 22.1 and 22.8, is the
major product in this solution (see ESI† for full characterisation
data). Now, the free H2 signal appears at 4.25 ppm with a peak
half-width of 190 Hz, which indicates more rapid ligand
exchange than in the corresponding DMSO derivative at 298 K.
As a consequence of changing the sulfoxide co-ligand from
DMSO-d6 to DPSO, an increased concentration of the desired
2,5-lutidine containing SABRE catalyst results. Additionally, the
rate of H2 exchange is increased. These factors result in a higher
polarisation transfer level to 2,5-lutidine in the presence of
DPSO than DMSO-d6. According to ab initio calculations, the
favouring of [IrCl(H)2(IMes)(DPSO)(2,5-lutidine)] over
[IrCl(H)2(IMes)(DPSO)2] has increased to 21.8 kJ mol
1; this is
reective of the cone angle of DPSO being 10% larger than that
of DMSO.30 This increase in the steric parameter for the sulf-
oxide ligandmay in turn reduce its binding affinity for the metal
centre. Consequently, 2,5-lutidine may be able to more effec-
tively compete for the equatorial ligand site.
Employing the aliphatic sulfoxides, tetramethylene sulfoxide
and dibutylsulfoxide, resulted in signal gains for H6 of 2,5-
lutidine of 131  21 and 40  8 fold respectively which are
therefore similar to those achieved with DMSO-d6. Interestingly,
no evidence of polarisation transfer into the undeuterated alkyl-
sulfoxide co-ligands is observed in the 1HNMR spectra recorded
aer SABRE transfer at 70 G which may be due to short
magnetic state lifetimes. In contrast, ca. 20-fold per proton
signal gains were quantied for the CH resonances of the aryl
rings in DPSO. This indicates that some polarisation transfer is
occurring to the bound DPSO ligand. It is hypothesised there-
fore that deuteration of the sulfoxide co-ligand would further
improve the efficiency of SABRE catalysis due to reduced spin-
dilution.28 SABRE polarisation transfer to DMSO from
[IrCl(H)2(DMSO)2(IMes)] has previously been reported.
29
Role of halide ligand in SABRE transfer
The effect of the halide ligand on the SABRE performance was
explicitly probed by the synthesis of the related bromide and
iodide containing complexes, prior to studying their reaction
with 2,5-lutidine in the presence of DPSO and 3 bar p-H2. When
[IrBr(COD)(IMes)] is utilised, the 1H NMR signal gain for the H6
proton of 2,5-lutidine was reduced to 570  18 and a further
reduction to a 171 14-fold signal enhancement was quantied
with the precatalyst [IrI(COD)(IMes)]. The reactivity of the cor-
responding dihydride products is readily apparent through
their effects on the free H2 signal, which shis to 4.19 and
4.04 ppm respectively with corresponding peak half-widths of
255 and 450 Hz. We deduce from these data that the rate of
ligand exchange in [IrX(H)2(IMes)(DPSO)(2,5-lutidine)]
increases for X ¼ Cl < Br < I. Hence, these data suggest the
signal enhancements become limited by catalyst lifetime.
Effect of counter ion on active complex
Our study so far shows that neutral catalysts with a bound
halide ligand are responsible for polarisation transfer to 2,5-
lutidine in dichloromethane-d2. We wished to probe whether
forcing the formation of a classical charged SABRE complex
could further improve signal gains. To achieve this, we
attempted to remove the halide ligand and replace it with a non-
chelating counter ion. Therefore, the [Ir(COD)(IMes)(2,5-luti-
dine)]BF4 pre-catalyst was synthesised from [IrCl(COD)(IMes)],
2,5-lutidine and AgBF4 as detailed in the ESI.† Subsequently,
this pre-catalyst was activated under the same conditions
previously employed by exposure to 3 bar H2 in the presence of
2,5-lutidine (15 mM) and DPSO (20 mM) in dichloromethane-d2
for 1 h at room temperature. Aer SABRE transfer under 3 bar p-
H2 in a 70 G polarisation transfer eld a signicantly dimin-
ished signal enhancement of just 19  8 fold was detected for
H6 of 2,5-lutidine. No hydride resonances were seen in these 1H
NMR spectra and no discernible active SABRE complexes could
be identied. However, the addition of excess Cl to this system
reformed the expected [IrCl(H)2(IMes)(DPSO)(2,5-lutidine)]
product and this restored the SABRE effect. SABRE transfer
© 2021 The Author(s). Published by the Royal Society of Chemistry Chem. Sci.













































































































using [Ir(COD)(IMes)(2,5-lutidine)]BF4 was also attempted in
methanol-d4, however, no polarisation transfer to 2,5-lutine was
observed.
In a related experiment, using the [IrCl(COD)(IMes)] pre-
catalyst in dichloromethane-d2 the addition of excess chloride
resulted in no discernible change in SABRE signal enhance-
ment which indicates that the polarisation transfer efficiency is
independent of chloride concentration once the SABRE catalyst
of type [IrCl(H)2(IMes)(DPSO)(2,5-lutidine)] is formed (see ESI†).
Role of the NHC ligand in active SABRE transfer
The identity of the NHC has also been reported to inuence the
level of polarisation transfer resulting under SABRE.14,31,32 A
series of six NHCs were therefore screened to probe their effect
(a full summary is given in the ESI, Fig. S13†). Unlike in previous
studies, deuteration of the IMes ligand resulted in no signi-
cant change in the 1H NMR signal enhancements seen for 2,5-
lutidine.15,28,33,34 Introducing chlorine atoms into the imidazole
backbone instead of protons resulted in a comparable 756  74
fold signal gain. Additionally, when the methyl groups located
in the para-position of the aryl rings were replaced with chlorine
or –CO2Me, reduced signal enhancements of 663  31 and 619
 44 were quantied respectively. However, when the para-
methyl groups of IMes were replaced by tert-butyl, a 891  49-
fold signal enhancement for the H-6 resonance of 2,5-lutidine
was quantied for DPSO as the co-ligand. This reects a 30%
improvement when compared to the results obtained with the
IMes ligand.
The remaining 1H resonances of 2,5-lutidine also receive
polarisation under these conditions with 635  40, 868  68,
240 12 and 248 8-fold signal gains for the H3, H4, ortho-CH3
and meta-CH3 sites respectively. When the SABRE sample con-
taining the tert-butyl derived catalyst was cooled to 243 K, the
presence of two minor hydride resonances at d13.5 and18.7
is revealed. These are attributed to the analogous bis-DPSO
complex that was described previously for the IMes derived
catalyst. The ratio of the active SABRE catalyst to the bis-DPSO
complex was estimated to be 98 : 2. Additionally, the rate of
H2 exchange appears to be slower in the catalyst system formed
when using the tert-butyl derived NHC catalyst. This is evi-
denced by the free H2 peak in the NMR spectra appearing at dH
4.36 with a peak half width of 70 Hz. This is a downeld shi
when compared to that seen with [IrCl(H)2(IMes)(DPSO)(2,5-
lutidine)], which exhibited a free H2 peak at dH 4.25 and
a peak half width of 190 Hz. This indicates a reduction in the
rate of H2 exchange which is consistent with an increase in
catalyst lifetime; such observations would explain why higher
signal enhancements are achieved if the complexes lifetimes are
limiting.
Effect of temperature on the SABRE hyperpolarisation of 2,5-
lutidine
As stated, the broad free H2 and hydride signals are indicative of
rapid ligand exchange on the active SABRE complexes at 298 K.
Indeed, the rates of loss of 2,5-lutidine or hydride from the
active catalyst were too fast to be accurately determined at 298 K
using EXSY.35 It was hypothesised that cooling the SABRE
samples may increase the lifetime of the catalyst to be closer to
that which has been shown both computationally36 and exper-
imentally14 to be optimal. Therefore, a sample containing the
tert-butyl derived catalyst ([IrCl(COD)(1,3-bis(4-tert-butyl-2,6-
dimethylphenyl)imidazole-2-ylidine)]), 2,5-lutidine and DPSO
in dichloromethane-d2 was cooled to the desired temperature
for 1minute prior to the SABRE transfer being conducted in a 70
G eld.
Aer cooling the sample to 283 K, a SABRE derived signal
enhancement of 956 38 was observed; a modest improvement
on the 891  49-fold signal gain previously detected at 298 K
resulted. However, conducting the SABRE catalysis at 273 K
yielded a signicantly improved 1442  84-fold signal gain at
9.4 T, which corresponds to a ca. 4.5% polarisation level.
Further cooling the sample to 263 K did not give further benets
and a 934 83-fold signal gain was quantied for 2,5-lutidine at
this temperature. Therefore, we propose that conducting the
SABRE hyperpolarisation of these weakly binding substrates at
273 K gives the optimum catalyst lifetime when using our co-
ligand approach.
To probe this effect more precisely, the rate of 2,5-lutidine
loss from the active catalyst was determined by EXSY. At 273 K
the rate of this process was quantied to be 4.33  0.02 s1
which is extremely close to the ca. 4.5 s1 which is predicted to
be optimal by Barskiy et al.36 At both 283 and 263 K, these values
deviate away from optimum and rates of 14.84  0.50 and 0.89
 0.02 s1 are quantied respectively. Eyring–Polanyi analysis
across a temperature range of 243–283 K reveals a DGs298
59.89 kJ mol1 for this process. When probing the loss of axially
bound DPSO from [IrCl(H)2(IMes)(DPSO)(2,5-lutidine)] at 273 K,
no exchange could be detected on the timescale of SABRE using
EXSY.
Expanding the substrate scope
The generality of this method to sensitise the NMR detection of
other weakly binding substrates with functional groups adja-
cent to their ligation site was also investigated. Fig. 3 shows the
structures of the 11 other substrates examined in this study.
They have been made amenable to SABRE by this co-ligand
strategy. For clarity, their corresponding 1H NMR signal
enhancements are displayed with and without the DPSO co-
ligand. At 298 K, 2-picoline, which until recently21 has been
previously reported as being unable to receive SABRE derived
polarisation,22 yields a 403  49-fold ortho-proton signal
enhancement at 9.4 T when examined using our co-ligand
approach. When repeating the SABRE transfer at 273 K, a 885
 72-fold signal enhancement is observed at 9.4 T which
equates to ca. 1.25% polarisation. This compares favourably to
use of the bidentate PHOX ligand;21 this yields 1H SABRE NMR
signal gains of 132-fold for the ortho-proton of 2-picoline at 8.5 T
(ca. 0.45% polarisation).
More sterically demanding 2-ethyl pyridine and 2-iso-
propylpyridine also become hyperpolarised by SABRE but their
ortho proton signal gains are now just 83  6 and 1.4  0.2-fold
respectively aer SABRE transfer at 298 K. Interestingly, the
Chem. Sci. © 2021 The Author(s). Published by the Royal Society of Chemistry













































































































decrease in signal enhancement is mirrored by a shi in the
resonance of the free H2 and an increase in peak half-width. For
2-picoline, the free H2 resonance appears at 4.27 ppm with
a peak half width of 150 Hz, whereas for 2-ethyl and 2-ispropyl
pyridine the H2 resonance is seen at 3.36 and 2.27 ppm, with
peak half widths of ca. 550 and 700 Hz respectively. This high-
lights how both ligand exchange and SABRE enhancements
remain sensitive to ligand binding effects even in related
systems despite this co-ligand strategy. Pleasingly, by conduct-
ing the SABRE catalysis at 273 K, the signal gains for 2-ethyl
pyridine and 2-isopropyl pyridine could be also improved to 570
 38 and 7  1-fold respectively.
Additionally, we were able to transfer SABRE derived hyper-
polarisation to 2,6-lutidine and a 153  24-fold signal gain for
the meta proton was quantied aer SABRE at 273 K. This
sterically hindered and weakly binding substrate is reported to
be unable to receive magnetisation under standard SABRE
conditions22 or when using the bidentate PHOX catalyst.21 2-
Hydroxy pyridine also gave improved signal enhancements
when DPSO was utilised. The signal enhancement for its H6
resonance was 92  13-fold at 9.4 T. Similarly, the pyrimidine
motif showed substantial signal improvements could be ach-
ieved in a range of mono and bis-methylated derivatives. A
signal gain of 1532  88-fold was quantied for 2,4-dime-
thylpyrimidine (ca. 4.8% polarisation) which is signicant as no
signal gain was recorded under standard SABRE conditions. 2-
Methylpyrimidine also performs well using the optimised
conditions and a 418  54-fold signal enhancement is quanti-
ed. Very recently the hyperpolarisation of 2-picoline has been
reported to be up to 25  7-fold using an acetonitrile co-ligand
in methanol-d4.
37
The SABRE hyperpolarisation of quinoline is also signi-
cantly improved to 2102 105-fold when compared to just 4.4
0.4-fold when no DPSO is present in dichloromethane-d2. The
SABRE hyperpolarisation of quinoline in methanol-d4 has
previously been reported to be ca. 60-fold at 9.4 T.38 Finally,
chloroquine, an anti-viral agent that has recently gained
signicant attention due to its use as a prospective COVID-19
treatment,39–41 also showed 1H SABRE polarisation. In the
presence of DPSO, a 217  57-fold signal gain was quantied,
however, when it is absent no signal gain is observed. The
appearance of the hydride region in these experiments is
consistent with the formation of the corresponding highly
reactive complex of type [IrCl(H)2(NHC)(DPSO)(substrate)] as
the major product. The signicant enhancements seen for
quinoline are consistent with the DFT ndings presented earlier
which suggest greater binding affinity for quinoline than 2,5-
lutidine despite the bicyclic nature of the ring system.
SABRE polarisation transfer to 13C and 15N nuclei
As a nal demonstration of this co-ligand strategy, polarisation
transfer to 13C and 15N nuclei was achieved. A sample con-
taining [IrCl(COD)(1,3-bis(4-tert-butyl-2,6-dimethylphenyl)
imidazole-2-ylidine)] (5 mM), DPSO (20 mM) and 2,5-lutidine
(20mM) in dichloromethane-d2was exposed to 3 bar p-H2 at 273
K in a 0.5 G polarisation transfer eld. The subsequent 13C NMR
spectrum is displayed in Fig. 4 and shows a 1424  204-fold
enhancement of the C2 of 2,5-lutidine (d 155.2). Additionally,
Fig. 3 1H NMR SABRE hyperpolarisation levels (fold) for the indicated
ortho proton achieved in a range of weakly binding N-heterocycles at
9.4 T under the following conditions: [IrCl(COD)(1,3-bis(4-tert-butyl-
2,6-dimethylphenyl)imidazole-2-ylidine)] (5 mM), DPSO (20 mM) and
substrate (20 mM) in dichloromethane-d2 with 3 bar p-H2 after
polarisation transfer a 70 G field after cooling the sample for 1 minute
at 273 K. CoL ¼ signal enhancement for ortho-1H in the presence of
DPSO. No CoL ¼ signal enhancement for ortho-1H in the absence of
DPSO. [a]No observable signal enhancement. [b]Signal formeta proton.
Fig. 4 SABRE hyperpolarisation using [IrCl(COD)(1,3-bis(4-tert-butyl-
2,6-dimethylphenyl)imidazole-2-ylidine)] (5 mM), DPSO (20 mM) and
2,5-lutidine (20 mM) in dichloromethane-d2 with 3 bar p-H2 after
polarisation transfer at 273 K. (a) SABRE hyperpolarised 13C NMR
spectrum after polarisation transfer at 0.5 G. (b) SABRE hyperpolarised
15N NMR spectrum after polarisation transfer at 3.5 mG.
© 2021 The Author(s). Published by the Royal Society of Chemistry Chem. Sci.













































































































strong polarisation is seen throughout the carbon resonances
with even the remote methyl groups being visible. Similarly,
when a 15N{1H}3–6,42 NMR spectrum is obtained aer the same
sample is exposed to p-H2 in a 3.5 mG eld, a 5048  201-fold
enhancement is seen at 9.4 T for the 15N resonance of 2,5-luti-
dine at d 312.5.
Conclusions
In summary, we present results that demonstrate how a co-
ligand strategy can be used to successfully hyperpolarise
weakly binding substrates using the signal amplication by
reversible exchange methodology. Each of the substrates have
functional groups in their ortho position that hinder their
binding ability. Signal enhancements up to 1442  84-fold are
achieved for 2,5-lutidine. This is all the more remarkable as
such substrates have previously been shown to be inaccessible
to the SABRE technique when the commonly used [IrCl(CO-
D)(IMes)] pre-catalyst is employed. Typically, this is due to the
inability to form an active SABRE catalyst of type [Ir(H)2(-
IMes)(sub)3]Cl due to steric congestion around themetal centre.
Our strategy hinges on the use of a sulfoxide co-ligand to
allow the formation of an active SABRE catalyst of the type
[IrCl(H)2(NHC)(sulfoxide)(substrate)]. When [IrCl(COD)(IMes)]
is exposed to H2 in the presence of dimethylsulfoxide-d6 (DMSO-
d6) and 2,5-luditine a 1 : 2 mixture of [IrCl(H)2(IMes)(DMSO-
d6)(2,5-lutidine)] and [IrCl(H)2(IMes)(DMSO-d6)2] were formed.
When the sample was exposed to p-H2 in a 70 G polarisation
transfer eld polarisation transfer to 2,5-lutidine was observed.
However, the presence of [IrCl(H)2(IMes)(DMSO-d6)2] in solu-
tion acts to rapidly consume p-H2 which is evidenced by
broadening of the resonances for its hydride ligands and free H2
in the 1H NMR spectrum. We found that increasing the size of
the sulfoxide co-ligand inhibits the formation of the bis-
sulfoxide complex. Therefore, when diphenylsulfoxide (DPSO)
is utilised no evidence of the corresponding [IrCl(H)2(-
IMes)(DPSO)2] complex is observed and an increased signal
enhancement for 2,5-lutidine was quantied.
The effect of the N-heterocyclic carbene (NHC) was also
probed and a tert-butyl derived catalyst, [IrCl(COD)(1,3-bis(4-
tert-butyl-2,6-dimethylphenyl)imidazole-2-ylidine)],14 was
shown to yield a complex which gave the best SABRE polar-
isation transfer to 2,5-lutidine. Further improvements were also
discovered by cooling the sample to 273 K and a signal
enhancement of 1442  84-fold was achieved for 2,5-lutidine at
9.4 T aer SABRE transfer at 70 G. The origin of this effect was
determined to be due to the ameliorating the lifetime of the
active catalyst. The rate of 2,5-lutidine loss at 273 K was deter-
mined to be 4.33  0.02 s1 which is extremely close to the
predicted optimum of ca. 4.5 s1.36 Additionally, SABRE hyper-
polarised 13C and 15N NMR spectra were also recorded and
signal enhancements of up to 1424  204-fold and 5048  201-
fold were quantied respectively.
The scope of this method has been proven by expansion to 11
other substrates. The method is easy to implement as the
standard SABRE pre-catalysts simply need to be mixed with the
sulfoxide and substrate. It is noteworthy that the highest
reported SABRE polarisation levels of 2-picoline, which has
previously be reported for use as in vivo pH sensors,43,44 is given
under the conditions reported here.
The methodology presented here therefore greatly expands
the range of substrates amenable to the SABRE and is expected
to open up new applications for the technique in the future. For
example, as signal to noise scales with the square root of the
number of measurements, these hyperpolarisation levels reect
remarkable measurement time reductions. Many active phar-
maceuticals contain nitrogen heterocycles with sterically
hindered nitrogen centres such as those in the diabetes treat-
ment Januvia,45 the cancer treatments Zytiga46 and Sprycel,47 the
immunosuppressant Xeljanz48 and the gastrointestinal drug
Nexium.49 The route we illustrate here demonstrates how the
detection of key 1H, 13C or 15N resonances in such materials can
be achieved relatively simply in moments and work is being
undertaken to render the SABRE method compatible for in vivo
use.50–56
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